Spiramycin-chitosan Nanoparticles Decline Parasite Burden and Renovate Patent Histopathological Changes in Liver and Lung in Mice Experimentally Infected with Acute Toxoplasmosis

Behavioral Study of Mice Experimentally Infected with Toxoplasma gondii

Histopathological Evaluation of Iron and Iron chelator Deferoxamine in Experimentally Infected Mice with Toxoplasma gondii

Assessment of Protective Effect of Rutin Utilizing Advanced Intranasal Nanoparticulate System in Mice Model after Experimental Challenge with Pasteurella Multocida Isolated from

EFFICACY OF SOME DRUGS AND PATHOLOGICAL STUDIES ON TOXOPLASMA GONDII INFECTION IN MICE

Molecular and Biochemical Assessment of Certain Antioxidants as Potential Anti-Toxoplasmic Agents in Murine Toxoplasmosis

A new approach in treatment of chronic murine models of toxoplasmosis using nitrofurantoin antibiotic.

Silver Nanoparticles and Lactoferrin Ameliorate Immunocompromised Murine Cryptosporidiosis

Effect of Platelet Rich Plasma versus Conventional Therapy on Early and Late ME 49 Toxoplasma Gondii Infection in Immunocompromised Mice

Assessment of Nitazoxanide Loaded on Silver nanoparticles Efficacy on Treatment of Murine Model of Chronic Toxoplasmosis.